Vered Bisker Leib Compass Therapeutics, Inc. (CMPX) insider trading activity

Vered Bisker Leib is CHIEF EXECUTIVE OFFICER of Compass Therapeutics, Inc.. Currently has a direct ownership of 3.12 Million shares of CMPX, which is worth approximately $5.31 Million. The most recent transaction as insider was on Feb 08, 2024, when has been sold 49,198 shares (Common Stock) at a price of $1.45 per share, resulting in proceeds of $71,337. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.12M

0% 3M change

110.41% 12M change

Total Value Held $5.31 Million

Vered Bisker-Leib Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 08 2024	SELL Payment of exercise price or tax liability	$71,337 $1.45 p/Share	49,198 Reduced 1.55%	3,124,426 Common Stock
Jan 09 2024	BUY Grant, award, or other acquisition	$3,383,531 $1.93 p/Share	1,753,125 Added 35.58%	3,173,624 Common Stock
Nov 17 2023	SELL Payment of exercise price or tax liability	$96,622 $1.5 p/Share	64,415 Reduced 4.34%	1,420,499 Common Stock
Feb 08 2023	BUY Grant, award, or other acquisition	-	400,000 Added 21.22%	1,484,914 Common Stock
Nov 25 2022	SELL Open market or private sale	$8 $4.36 p/Share	2 Reduced 0.0%	1,060,414 Common Stock
Nov 23 2022	SELL Open market or private sale	$41,146 $4.3 p/Share	9,569 Reduced 0.89%	1,060,416 Common Stock
Nov 22 2022	SELL Open market or private sale	$62,552 $4.19 p/Share	14,929 Reduced 1.38%	1,069,985 Common Stock
Nov 21 2022	SELL Open market or private sale	$69,591 $4.34 p/Share	16,035 Reduced 1.46%	1,084,914 Common Stock
Nov 18 2022	SELL Open market or private sale	$27,394 $4.4 p/Share	6,226 Reduced 0.56%	1,107,175 Common Stock
Nov 16 2021	BUY Grant, award, or other acquisition	-	600,000 Added 35.02%	1,113,401 Common Stock

Also insider at

AYLA

Ayala Pharmaceuticals, Inc. Healthcare

Director

ADXSD

Advaxis, Inc.

Director